A systematic review of the social and economic burden of influenza in low- and middle-income countries.

OBJECTIVES The economic burden of seasonal influenza outbreaks as well as influenza pandemics in lower- and middle-income countries (LMIC) has yet to be specifically systematically reviewed. The aim of this systematic review is to assess the evidence of influenza economic burden assessment methods in LMIC and to quantify the economic consequences of influenza disease in these countries, including broader opportunity costs in terms of impaired social progress and economic development. METHODS We conducted an all language literature search across 5 key databases using an extensive list of key words for the time period 1950-2013. We included studies which explored direct costs (medical and non-medical), indirect costs (productivity losses), and broader economic impact in LMIC associated with different influenza outcomes such as confirmed seasonal influenza infection, influenza-like illnesses, and pandemic influenza. RESULTS We included 62 full-text studies in English, Spanish, Russian, Chinese languages, mostly from the countries of Latin American and the Caribbean and East Asia and Pacific with pertinent cost data found in 39 papers. Estimates for direct and indirect costs were the highest in Latin American and the Caribbean. Compared to high-income economies, direct costs in LMIC were lower and productivity losses higher. Evidence on broader impact of influenza included impact on the wider national economy, security dimension, medical insurance policy, legal frameworks, distributional impact, and investment flows. CONCLUSION The economic burden of influenza in LMIC encompasses multiple dimensions such as direct costs to the health service and households, indirect costs due to productivity losses as well as broader detriments to the wider economy. Evidence from sub-Saharan Africa and in pregnant women remains very limited. Heterogeneity of methods used to estimate cost components makes data synthesis challenging. There is a strong need for standardizing research, data collection and evaluation methods for both direct and indirect cost components.

[1]  R. Coker,et al.  An analysis of health system resources in relation to pandemic response capacity in the Greater Mekong Subregion , 2012, International Journal of Health Geographics.

[2]  A. Apisarnthanarak,et al.  Outbreak of Influenza A (2009) H1N1 among Thai Healthcare Workers: Is It Time to Integrate a Vaccination Program? , 2010, Infection Control & Hospital Epidemiology.

[3]  G. Sanders,et al.  Cost-Effectiveness in Health and Medicine , 2016 .

[4]  M. Drummond,et al.  The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  Ting Huang,et al.  Direct Medical Cost of Influenza-Related Hospitalizations among Severe Acute Respiratory Infections Cases in Three Provinces in China , 2013, PloS one.

[6]  R. Rivas-Ruiz,et al.  Costo-efectividad en la detección de influenza H1N1: datos clínicos versus pruebas rápidas , 2011 .

[7]  Fanjasoa Rakotomanana,et al.  Short message service sentinel surveillance of influenza-like illness in Madagascar, 2008-2012. , 2012, Bulletin of the World Health Organization.

[8]  Elizabeth Wishnick Dilemmas of securitization and health risk management in the People's Republic of China: the cases of SARS and avian influenza. , 2010, Health policy and planning.

[9]  A. Tasset-Tisseau,et al.  Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  N. Alvis-Guzmán,et al.  Costo efectividad de la vacunación contra influenza en menores de 2 años y mayores de 65 años en Colombia Cost effectiveness of influenza vaccination in children under 2 years old and elderly in Colombia , 2009 .

[11]  Piya Hanvoravongchai,et al.  Emerging infectious diseases in southeast Asia: regional challenges to control , 2011, The Lancet.

[12]  A K Sharma,et al.  Avian flu and possible human pandemic. , 2006, Indian pediatrics.

[13]  R. Rüttimann,et al.  [Impact on the direct medical cost related to the influenza virus during 2009 in children under 5 years compared to the period 2006-2008 in a pediatric hospital]. , 2012, Archivos argentinos de pediatria.

[14]  Weizhong Yang,et al.  Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009. , 2010, Vaccine.

[15]  A. Apisarnthanarak,et al.  Outbreaks of Influenza A Among Nonvaccinated Healthcare Workers: Implications for Resource-Limited Settings , 2008, Infection Control & Hospital Epidemiology.

[16]  O. Sarikaya,et al.  Avian influenza outbreak in Turkey through health personnel's views: a qualitative study , 2007, BMC public health.

[17]  N. Alvis-Guzman,et al.  Costo efectividad de la vacunación contra influenza en menores de 2 años y mayores de 65 años en Colombia , 2009 .

[18]  M. Jit,et al.  Estimating costs of care for meningitis infections in low- and middle-income countries. , 2015, Vaccine.

[19]  R. Hutubessy,et al.  WHO Guide for standardisation of economic evaluations of immunization programmes. , 2010, Vaccine.

[20]  Effectiveness and economical impact of vaccination against influenza among a working population in Moscow. , 1999, Vaccine.

[21]  G. Dayan,et al.  Cost-effectiveness of influenza vaccination in high-risk children in Argentina. , 2001, Vaccine.

[22]  Jianfeng He,et al.  Epidemiologic and Economic Burden of Influenza in the Outpatient Setting: A Prospective Study in a Subtropical Area of China , 2012, PloS one.

[23]  J. Gutiérrez,et al.  Vacunación contra influenza para adultos mayores en México: consideraciones económicas , 2005 .

[24]  M. Meltzer,et al.  Influenza cost and cost-effectiveness studies globally--a review. , 2013, Vaccine.

[25]  Fanjasoa Rakotomanana,et al.  Sentinel surveillance system for early outbreak detection in Madagascar , 2010, BMC public health.

[26]  M. Jit,et al.  Influenza vaccines in low and middle income countries , 2013, Human vaccines & immunotherapeutics.

[27]  Genming Zhao,et al.  The Clinical Characteristics and Direct Medical Cost of Influenza in Hospitalized Children: A Five-Year Retrospective Study in Suzhou, China , 2012, PloS one.

[28]  J. Herington Securitization of infectious diseases in Vietnam: the cases of HIV and avian influenza. , 2010, Health policy and planning.

[29]  S. Dowell,et al.  Field performance and new uses of rapid influenza testing in Thailand. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[30]  Richard D. Smith,et al.  Macroeconomic impact of a mild influenza pandemic and associated policies in Thailand, South Africa and Uganda: a computable general equilibrium analysis , 2013, Influenza and other respiratory viruses.

[31]  A. Tasset-Tisseau,et al.  Workplace Vaccination against Influenza in Malaysia: Does the Employer Benefit? , 2006, Journal of occupational health.

[32]  Harish Nair,et al.  Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis , 2011, The Lancet.

[33]  L. Jönsson,et al.  Influenza vaccination of the at-risk adults and elderly: measuring the long-term cost-effectiveness in an Argentinean Managed Care Organization , 2004 .

[34]  M. Jit,et al.  Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries , 2012, BMC Public Health.

[35]  M. García-Molina,et al.  [Economic evaluation of influenza vaccine applied to health personnel attending hospitalised oncological patients]. , 2008, Revista de salud publica.

[36]  Till Bärnighausen,et al.  Valuing vaccination , 2014, Proceedings of the National Academy of Sciences.

[37]  T. Uyeki,et al.  Reduction of Seasonal Influenza Transmission among Healthcare Workers in an Intensive Care Unit: A 4-Year Intervention Study in Thailand , 2010, Infection Control & Hospital Epidemiology.

[38]  松本 慶蔵,et al.  季節性インフルエンザ(Seasonal Influenza)の総括 , 2009 .

[39]  S. Dowell,et al.  A household survey to assess the burden of influenza in rural Thailand. , 2006, The Southeast Asian journal of tropical medicine and public health.

[40]  C. Toscano,et al.  Cost-effectiveness of Sick Leave Policies for Health Care Workers with Influenza-like Illness, Brazil, 2009 , 2011, Emerging infectious diseases.

[41]  N. A. Guzmán,et al.  Costo-efectividad de la vacunación contra influenza pandémica en mujeres embarazadas en Colombia , 2012 .

[42]  P. Crépey,et al.  Public health and economic benefits of new pediatric influenza vaccination programs in Argentina , 2012, Human vaccines & immunotherapeutics.

[43]  G. Hamadeh,et al.  Family physicians beliefs and attitudes regarding adult pneumococcal and influenza immunization in Lebanon. , 2011, Family practice.

[44]  L. Sun,et al.  A population-based study on incidence and economic burden of influenza-like illness in south China, 2007. , 2011, Public health.

[45]  S. Dowell,et al.  The cost of influenza in Thailand. , 2006, Vaccine.

[46]  I. Sam,et al.  High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia. , 2010, The Journal of infection.

[47]  M. Jit,et al.  The broader economic impact of vaccination: reviewing and appraising the strength of evidence , 2015, BMC Medicine.